Tenaya Therapeutics
Agent32Agent Readiness: 32/100. Below median. Measured by StartupHub.ai. Median 41.Trust79Data Trust: 79/100. Top 25%. Measured by StartupHub.ai. Median 61.Biotechnology company developing gene therapies and regenerative medicine for heart disease.
About
Tenaya Therapeutics is a clinical-stage biotechnology company dedicated to discovering, designing, developing, and delivering potentially curative gene therapies for heart disease. Their lead programs, TN-201 and TN-401, target MYBPC3-associated hypertrophic cardiomyopathy (HCM) and PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. They aim to address the underlying drivers of these debilitating conditions to improve and extend the lives of patients and their families.
Similar companies
A biotechnology company developing genetic therapies for rare disorders.
Shares Gene Therapy, Cardiovascular Disease
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, MedTech
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Shares Biotech, MedTech
Key facts
- Website
- tenayatherapeutics.com
- Headquarters
- South San Francisco, United States
- Founded
- 2016
- Employees
- 99
- Total funding
- $159M (Public Offering)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Mar 2025 | Public Offering | $53M | |
| 1 Mar 2021 | Series C | $106M | RTW Investments, RA Capital, Fidelity |
Tech stack
Detected on tenayatherapeutics.com, last scanned 31 Oct 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS, Bootstrap
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Mimecast
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Tenaya Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Tenaya Therapeutics is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Tenaya Therapeutics raised?
Tenaya Therapeutics has raised a total of $159M in funding. The most recent round on record is Public Offering.
How many employees does Tenaya Therapeutics have?
Tenaya Therapeutics has approximately 99 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Tenaya Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
